Category - Study
Kratom’s reputed pain-relief benefits could come from one of its metabolites
FDA Fails to Provide Credible Data and Science to Justify Scheduling Kratom as Schedule I Substance
House Study Committee on Risks Associated with Kratom sets final meeting